
News|Articles|August 1, 2004
Glycemic control and pulmonary function sustained throughout long-term use of inhalable insulin
Two studies evaluating the efficacy and long-term safety of the inhalable, rapid-acting dry powder insulin formulation (Exubera, Pfizer/Aventis) demonstrate that the drug was able to sustain glycemic control and pulmonary function in patients with type 2 diabetes
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Hospitals facing financial headwinds can't afford to ignore the mounting threats to 340B
2
LucyRx and Abarca to merge
3
4 things to know about the Abarca/LucyRx merger
4
FDA approves new sunscreen ingredient, first time in 20 years
5
































